Founded in 1963, The Chinese University of Hong Kong (CUHK) is a forward-looking comprehensive research university with a global vision and a mission to combine tradition with modernity and to bring together China and the West. It is ranked as one of the Top 50 institutions in the world1.
A European multinational pharmaceutical manufacturer in China (Beijing), recently engaged SeerPharma to conduct a mock TGA GMP inspection in preparation for an impending TGA audit. The operations had been inspected by the TGA in the past.
A leading pharmaceutical manufacturer in Vietnam requested SeerPharma to conduct an on-site review of a manufacturing line, in preparation for an impending European Union (EU) Good Manufacturing Practice (GMP) inspection.
Training is a core fundamental to a compliant Pharmaceutical Quality System. This aids in ensuring that manufactured products meet the required product standard that relate to safety, quality, and efficacy. Although training has been a main staple in the pharmaceutical industry for decades, the practice itself has had its challenges from internal...
Precision healthcare can offer and plan specific patient care, based on the genes, proteins, and other substances in a person’s body. Regarding cancer and rare diseases, precision healthcare most often means looking at how changes in certain genes or proteins in a person’s cells might affect their care and treatment options. Recent advances in...
The Therapeutic Goods Administration (TGA) is part of the Australian Federal Government’s Department of Health and regulates the supply, import, export, manufacturing, and advertising of therapeutic goods, including medicines in Australia.
Digital Transformation, Data Optimization, and Tech-Savvy Talent
SeerPharma is thrilled to welcome the 2023 Spring cohort of students studying Good Manufacturing Practice (GMP) at the University of Technology Sydney (UTS). This unique program is designed and delivered by SeerPharma in partnership with UTS. We’re thrilled to see close to 100 students now undergoing Postgraduate training in GMP with us at UTS....
If we could predict the future of the pharma manufacturing industry, we wouldn’t have been rattled by supply disruptions throughout the pandemic. And we would’ve been able to anticipate which products would unexpectedly experience weak demand. At the very least, we could’ve predicted which winning therapies to invest in! So why do we waste time...
SeerPharma has been engaged by multiple companies to conduct GMP audits in the Asia-Pacific region on behalf of Qualified Persons (QP) in Europe.
Copyright © SeerPharma
